Logo image of BMI

BADGER METER INC (BMI) Stock Fundamental Analysis

NYSE:BMI - New York Stock Exchange, Inc. - US0565251081 - Common Stock - Currency: USD

213.91  +5.33 (+2.56%)

After market: 213.91 0 (0%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to BMI. BMI was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. BMI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. BMI is not priced too expensively while it is growing strongly. Keep and eye on this one! BMI also has an excellent dividend rating. This makes BMI very considerable for dividend and growth and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year BMI was profitable.
In the past year BMI had a positive cash flow from operations.
BMI had positive earnings in 4 of the past 5 years.
Of the past 5 years BMI 4 years had a positive operating cash flow.
BMI Yearly Net Income VS EBIT VS OCF VS FCFBMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 14.82%, BMI belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
BMI has a Return On Equity of 20.12%. This is amongst the best in the industry. BMI outperforms 89.17% of its industry peers.
With an excellent Return On Invested Capital value of 16.98%, BMI belongs to the best of the industry, outperforming 94.17% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BMI is significantly above the industry average of 8.99%.
The last Return On Invested Capital (16.98%) for BMI is above the 3 year average (14.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.82%
ROE 20.12%
ROIC 16.98%
ROA(3y)11.8%
ROA(5y)11.43%
ROE(3y)16.02%
ROE(5y)15.19%
ROIC(3y)14.02%
ROIC(5y)13.42%
BMI Yearly ROA, ROE, ROICBMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

With an excellent Profit Margin value of 14.80%, BMI belongs to the best of the industry, outperforming 90.83% of the companies in the same industry.
In the last couple of years the Profit Margin of BMI has grown nicely.
Looking at the Operating Margin, with a value of 18.76%, BMI belongs to the top of the industry, outperforming 96.67% of the companies in the same industry.
In the last couple of years the Operating Margin of BMI has grown nicely.
Looking at the Gross Margin, with a value of 39.55%, BMI is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
In the last couple of years the Gross Margin of BMI has remained more or less at the same level.
Industry RankSector Rank
OM 18.76%
PM (TTM) 14.8%
GM 39.55%
OM growth 3Y3.07%
OM growth 5Y4.11%
PM growth 3Y4.34%
PM growth 5Y15.47%
GM growth 3Y-0.2%
GM growth 5Y0.98%
BMI Yearly Profit, Operating, Gross MarginsBMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BMI is still creating some value.
BMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BMI Yearly Shares OutstandingBMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
BMI Yearly Total Debt VS Total AssetsBMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 20.53 indicates that BMI is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 20.53, BMI belongs to the best of the industry, outperforming 94.17% of the companies in the same industry.
There is no outstanding debt for BMI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 20.53
ROIC/WACC1.64
WACC10.35%
BMI Yearly LT Debt VS Equity VS FCFBMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 4.10 indicates that BMI has no problem at all paying its short term obligations.
BMI has a Current ratio of 4.10. This is in the better half of the industry: BMI outperforms 72.50% of its industry peers.
BMI has a Quick Ratio of 2.87. This indicates that BMI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.87, BMI is in the better half of the industry, outperforming 72.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.1
Quick Ratio 2.87
BMI Yearly Current Assets VS Current LiabilitesBMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.97% over the past year.
BMI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.31% yearly.
The Revenue has grown by 20.25% in the past year. This is a very strong growth!
BMI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.16% yearly.
EPS 1Y (TTM)38.97%
EPS 3Y22.7%
EPS 5Y15.31%
EPS Q2Q%22.73%
Revenue 1Y (TTM)20.25%
Revenue growth 3Y18.25%
Revenue growth 5Y10.16%
Sales Q2Q%11.95%

3.2 Future

BMI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.97% yearly.
BMI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.77% yearly.
EPS Next Y36.86%
EPS Next 2Y25.43%
EPS Next 3Y19.29%
EPS Next 5Y15.97%
Revenue Next Year17.01%
Revenue Next 2Y12.76%
Revenue Next 3Y10.9%
Revenue Next 5Y9.77%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BMI Yearly Revenue VS EstimatesBMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
BMI Yearly EPS VS EstimatesBMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 53.08, which means the current valuation is very expensive for BMI.
The rest of the industry has a similar Price/Earnings ratio as BMI.
When comparing the Price/Earnings ratio of BMI to the average of the S&P500 Index (28.46), we can say BMI is valued expensively.
With a Price/Forward Earnings ratio of 43.30, BMI can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BMI is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of BMI to the average of the S&P500 Index (92.56), we can say BMI is valued rather cheaply.
Industry RankSector Rank
PE 53.08
Fwd PE 43.3
BMI Price Earnings VS Forward Price EarningsBMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BMI is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as BMI.
Industry RankSector Rank
P/FCF 48.13
EV/EBITDA 32.26
BMI Per share dataBMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

BMI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of BMI may justify a higher PE ratio.
A more expensive valuation may be justified as BMI's earnings are expected to grow with 19.29% in the coming years.
PEG (NY)1.44
PEG (5Y)3.47
EPS Next 2Y25.43%
EPS Next 3Y19.29%

7

5. Dividend

5.1 Amount

BMI has a yearly dividend return of 0.65%, which is pretty low.
Compared to an average industry Dividend Yield of 1.86, BMI pays a better dividend. On top of this BMI pays more dividend than 85.83% of the companies listed in the same industry.
With a Dividend Yield of 0.65, BMI pays less dividend than the S&P500 average, which is at 2.27.
Industry RankSector Rank
Dividend Yield 0.65%

5.2 History

On average, the dividend of BMI grows each year by 12.13%, which is quite nice.
BMI has paid a dividend for at least 10 years, which is a reliable track record.
BMI has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)12.13%
Div Incr Years18
Div Non Decr Years18
BMI Yearly Dividends per shareBMI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

BMI pays out 28.40% of its income as dividend. This is a sustainable payout ratio.
The dividend of BMI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.4%
EPS Next 2Y25.43%
EPS Next 3Y19.29%
BMI Yearly Income VS Free CF VS DividendBMI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
BMI Dividend Payout.BMI Dividend Payout, showing the Payout Ratio.BMI Dividend Payout.PayoutRetained Earnings

BADGER METER INC

NYSE:BMI (1/31/2025, 8:14:04 PM)

After market: 213.91 0 (0%)

213.91

+5.33 (+2.56%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-31 2025-01-31/bmo
Earnings (Next)N/A N/A
Inst Owners95.03%
Inst Owner Change-0.68%
Ins Owners0.5%
Ins Owner Change-0.18%
Market Cap6.29B
Analysts73.33
Price Target224.93 (5.15%)
Short Float %5.03%
Short Ratio7.55
Dividend
Industry RankSector Rank
Dividend Yield 0.65%
Yearly Dividend0.99
Dividend Growth(5Y)12.13%
DP28.4%
Div Incr Years18
Div Non Decr Years18
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.17%
Min EPS beat(2)-3.67%
Max EPS beat(2)8.01%
EPS beat(4)3
Avg EPS beat(4)6.33%
Min EPS beat(4)-3.67%
Max EPS beat(4)19.54%
EPS beat(8)6
Avg EPS beat(8)8.03%
EPS beat(12)9
Avg EPS beat(12)8.32%
EPS beat(16)13
Avg EPS beat(16)7.72%
Revenue beat(2)1
Avg Revenue beat(2)1.36%
Min Revenue beat(2)-2.72%
Max Revenue beat(2)5.44%
Revenue beat(4)2
Avg Revenue beat(4)2.11%
Min Revenue beat(4)-2.72%
Max Revenue beat(4)6.63%
Revenue beat(8)6
Avg Revenue beat(8)4.21%
Revenue beat(12)9
Avg Revenue beat(12)3.78%
Revenue beat(16)12
Avg Revenue beat(16)2.97%
PT rev (1m)0.38%
PT rev (3m)-1.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE 53.08
Fwd PE 43.3
P/S 7.83
P/FCF 48.13
P/OCF 44.65
P/B 10.64
P/tB 14.73
EV/EBITDA 32.26
EPS(TTM)4.03
EY1.88%
EPS(NY)4.94
Fwd EY2.31%
FCF(TTM)4.44
FCFY2.08%
OCF(TTM)4.79
OCFY2.24%
SpS27.33
BVpS20.1
TBVpS14.53
PEG (NY)1.44
PEG (5Y)3.47
Profitability
Industry RankSector Rank
ROA 14.82%
ROE 20.12%
ROCE 22.38%
ROIC 16.98%
ROICexc 27.58%
ROICexgc 45.62%
OM 18.76%
PM (TTM) 14.8%
GM 39.55%
FCFM 16.26%
ROA(3y)11.8%
ROA(5y)11.43%
ROE(3y)16.02%
ROE(5y)15.19%
ROIC(3y)14.02%
ROIC(5y)13.42%
ROICexc(3y)19.32%
ROICexc(5y)17.53%
ROICexgc(3y)35.35%
ROICexgc(5y)31.15%
ROCE(3y)18.48%
ROCE(5y)17.73%
ROICexcg growth 3Y15.33%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y15.07%
ROICexc growth 5Y11.25%
OM growth 3Y3.07%
OM growth 5Y4.11%
PM growth 3Y4.34%
PM growth 5Y15.47%
GM growth 3Y-0.2%
GM growth 5Y0.98%
F-Score8
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 32.59%
Cap/Sales 1.27%
Interest Coverage 250
Cash Conversion 77.38%
Profit Quality 109.89%
Current Ratio 4.1
Quick Ratio 2.87
Altman-Z 20.53
F-Score8
WACC10.35%
ROIC/WACC1.64
Cap/Depr(3y)29.79%
Cap/Depr(5y)31.27%
Cap/Sales(3y)1.36%
Cap/Sales(5y)1.6%
Profit Quality(3y)117.92%
Profit Quality(5y)134.44%
High Growth Momentum
Growth
EPS 1Y (TTM)38.97%
EPS 3Y22.7%
EPS 5Y15.31%
EPS Q2Q%22.73%
EPS Next Y36.86%
EPS Next 2Y25.43%
EPS Next 3Y19.29%
EPS Next 5Y15.97%
Revenue 1Y (TTM)20.25%
Revenue growth 3Y18.25%
Revenue growth 5Y10.16%
Sales Q2Q%11.95%
Revenue Next Year17.01%
Revenue Next 2Y12.76%
Revenue Next 3Y10.9%
Revenue Next 5Y9.77%
EBIT growth 1Y39.05%
EBIT growth 3Y21.88%
EBIT growth 5Y14.69%
EBIT Next Year60.76%
EBIT Next 3Y25.15%
EBIT Next 5Y19.09%
FCF growth 1Y76.1%
FCF growth 3Y6.81%
FCF growth 5Y13.67%
OCF growth 1Y76.54%
OCF growth 3Y7.12%
OCF growth 5Y12.78%